Abstract
Background Numerous observational studies have shown an association between higher circulating 25 hydroxyvitamin D (vitamin D) and lower body mass index (BMI). Whether this represents a causal effect remains unclear. Mendelian randomization (MR) is an approach to causal inference that uses genetic variants as instrumental variables to estimate the effect of exposures on outcomes of interest. MR estimates are not biased by confounding, reverse causation and other biases in the same way as conventional observational estimates. In this study, we used MR with new data on genetic variants associated with vitamin D to estimate the effect of vitamin D on BMI.
Methods We selected single nucleotide polymorphisms (SNPs) which were associated with vitamin D in a recent large genome-wide association study (GWAS) at genome-wide significance as instruments for vitamin D. We used inverse variance weighted models and further assessed individual SNPs that showed evidence of an effect, and biologically informed SNPs located in genetic regions previously associated with vitamin D, for associations with other traits at genome-wide significance, using Wald ratio estimation.
Result Our main results showed no evidence of an effect of vitamin D on BMI (estimated standard deviation change in BMI per standard deviation change in vitamin D: -0.003, 95% confidence interval [-0.06, 0.06]). This was also supported by pleiotropy robust sensitivity analyses. Individual SNPs that showed evidence of an effect of vitamin D on either lower or higher BMI were strongly associated with numerous other traits suggesting high levels of horizontal pleiotropy. Biologically informed SNPs showed no evidence of a causal effect of vitamin D on BMI and showed substantially less evidence of pleiotropic effects.
Conclusion The observed association between vitamin D and BMI is unlikely to be due to a causal effect of vitamin D on BMI. We also show how additional evidence can be incorporated into an MR study to interrogate individual SNPs for potential pleiotropy and improve interpretation of results.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Medical Research Council (MRC) and the University of Bristol support the MRC Integrative Epidemiology Unit [MC_UU_00032/1].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All analysis was conducted using publicly available data accessed through the IEU OpenGWAS infrastructure.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this study is available at https://gwas.mrcieu.ac.uk/.
